Teruji Tanaka

Therapeutic and diagnostic potential of a vasopressin‐2 antagonist for impaired water handling in cirrhosis

Y. Yamamura, A. Ohnishi, K. Okada, 1998, Clinical pharmacology and therapeutics.

Kinetics and dynamics of enalapril in patients with liver cirrhosis

T. Ishizaki, A. Ohnishi, K. Kubota, 1989, Clinical pharmacology and therapeutics.

Effects of a sustained thromboxane synthase inhibition on exercise‐induced changes in eicosanoid formation, catecholamine concentration, and platelet aggregation in humans

T. Ishizaki, T. Tanaka, H. Echizen, 1992, Clinical pharmacology and therapeutics.

The production of colony-stimulating factors by thyroid carcinoma is associated with marked neutrophilia and eosinophilia.

F. Mizorogi, H. Sato, T. Nakada, 1996, Internal medicine.

Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.

T. Tanaka, Y. Takekuma, K. Takagi, 2000, Internal medicine.

Comparison of the Pharmacokinetics of E2020, A New Compound for Alzheimer's Disease, in Healthy Young and Elderly Subjects

A. Ohnishi, Y. Tomono, J. Hasegawa, 1993, Journal of clinical pharmacology.